Product Newsbmd enters two new diagnostic markets with the launch of FIDIS™ kits for infectious and genetic diseases
Product NewsAXIS-SHIELD ANNOUNCES LAUNCH OF FIRST ASSAY UNDER AXSYM® XTRA PROGRAMME – PART OF PROJECT TO EXPAND AXSYM’S BROAD TEST MENU
Product NewsAstro Instrumentation, LLC and Immunicon Corporation Team Up to Provide Automated Breakthrough System for Cancer Detection
Product NewsGuava Technologies Announces FDA 510(k) Clearance of Guava® EZCD4 System for CD4 Monitoring
Product NewsRussian Neonatal Screening Laboratories to Boost Scope and Capacity with New PerkinElmer Reagents and Technologies
Product NewsEMEA Adopts Positive Opinion on First European Product Containing Delta Biotechnology’s Recombumin® (recombinant human albumin)
Product NewsANIARA CORPORATION GROWTH DRIVEN BY GLOBAL PRESENCE AND EXTENSIVE PRODUCT OFFERING FOR MEDICAL EXPLORATION AND DISCOVERY
Product NewsOlympus unveils major expansion in Paris immunoassay R&D center and new combined manufacturing and R&D clinical chemistry facility in Japan
Product NewsAXIS-SHIELD PLC SIGNS AGREEMENT WITH DPC REGARDING ANTI-CCP TEST FOR EARLY DETECTION OF RHEUMATOID ARTHRITIS ON THE IMMULITE® AUTOMATED IMMUNOASSAY SYSTEM
Product NewsSYMPHOGEN’S SUCCESS IN MANUFACTURING CONSISTENT BATCHES OF POLYCLONAL ANTIBODIES FOR CLINICAL TRIALS ATTRACTS NEW USD 25 MILLION INVESTMENT
